Gliclazide sustained-release tablets

[Approval Number] National Drug approval H20066231

[Trade name] Lininger

[Indication] for adults with type 2 diabetes whose diet control, exercise therapy and weight loss alone are insufficient to control blood glucose levels.

[Specification] 30mg